We are an investment group.

Trendlines invents, discovers, invests in, and incubates innovation-based medical and agricultural technologies.

We invest principally through our incubators: our two Israeli government-franchised incubators, Trendlines Medical and Trendlines Agtech, our Singapore incubators, Trendlines Medical Singapore and AFIC –  an agrifood incubator,  our in-house innovation center, Trendlines Labs, and our funds: the Trendlines Agrifood Fund and the Bayer Trendlines Ag Innovation Fund. As intensely hands-on investors, we are involved in all aspects of our portfolio companies from technology development to business building.  Simply stated, we create and develop companies to improve the human condition.

It’s almost impossible to describe Trendlines without talking about Steve Rhodes and Todd Dollinger,
the company’s founders, chairmen, and CEOs. The Trendlines story rests on Steve and Todd’s longstanding, solid business relationship, and beyond that, their friendship.

Like all strong partnerships, mix and balance make it work.

It combines Steve’s 35 years of finance, banking, and investment experience with Todd’s 35 years of business development, investment, sales, and marketing expertise. Partnership plays a vital role at Trendlines; in fact, it’s at the very core of our culture. The dedicated Trendlines team of nearly 40 employees brings together wide-ranging expertise (banking, finance, law, R&D, business development, communications, media, and marketing) to capitalize on Trendlines’ partnerships with entrepreneurs, investors, strategic players, inventors, and governments.

The early ’90s saw Israel take its first steps on its journey toward becoming the “start-up nation.” In 1993, Steve and Todd founded Trendlines International as a business development consultancy focused on assisting and guiding innovation-based Israeli companies in the complex U.S. market. Todd and Steve were among the trailblazers in Israel’s fledgling high-tech start-up nationhood. See Trendlines timeline. From the start, Steve and Todd said two things about working with early-stage, innovation-based business: It’s about the people, and it’s about building relationships. These two principles remain at the foundation of their philosophy.

Fast-forward 20 years.

Today, The Trendlines Group is a publicly traded company on the Singapore Stock Exchange (SGX: 42T) and in the United States as an American Depositary Receipt (ADR) on the OTCQX® International (OTCQX: TRNLY).

Through its business units — Trendlines Medical, Trendlines Agtech, Trendlines Labs, and Trendlines Medical Singapore — The Trendlines Group is an award-winning organization known for inventing, investing, partnering, and developing medical and agtech companies to improve the human condition. See the Trendlines story in 3 minutes.


It’s almost impossible to describe Trendlines without mentioning the longstanding business partnership of Steve Rhodes (left) and Todd Dollinger (right), the company’s founders, chairmen, and CEOs.